India · Delayed Price · Currency is INR NGL Fine-Chem Company Description
NGL Fine-Chem Limited manufactures and sells pharmaceuticals and intermediates for usage in veterinary and human health in India, Europe, the Asia Pacific, the United States, and internationally.
The company offers animal health pharmaceutical ingredients, such as homidium chloride, nitroxynil, clorsulon, parvaquone, buparvaquone, isometamidium chloride hydrochloride, toldimfos sodium, butaphosphan, imidocarb dipropionate, triclabendazole, rafoxanide, diminazene aceturate, s-methoprene, carprofen, diminazene diaceturate, ractopamine HCI, toltrazuril, decoquinate, amitraz, marbofloxacin, flunixin meglumine, praziquantel, fenbendazole, and xylazine hydrochloride.
It also provides human health pharmaceutical ingredients, including nitazoxanide and atovaquone; and intermediates and specialty chemicals comprising 1,4,7-Trimethyl-1,4,7-Triazacylononane and N-ethyl glucamine.
In addition, the company offers finished dosage forms, including diminazene aceturate granules and homidium chloride tablets.
NGL Fine-Chem Limited was incorporated in 1981 and is based in Mumbai, India.
| Country | India |
| Founded | 1981 |
| Industry | Medicinal Chemicals and Botanical Products |
| Employees | 520 |
| CEO | Rahul Nachane |
Contact Details
Address: 301, E Square Mumbai, 400057 India | |
| Phone | 91 22 4084 2222 |
| Website | nglfinechem.com |
Stock Details
| Ticker Symbol | 524774 |
| Exchange | Bombay Stock Exchange |
| Fiscal Year | April - March |
| Reporting Currency | INR |
| SIC Code | 2833 |
Key Executives
| Name | Position |
|---|---|
| Rahul Nachane | Chief Executive Officer |
| Rajesh Lawande | Chief Financial Officer |